Indices | Omega-3 (n = 30) | Placebo (n = 30) | P†| P††|
---|---|---|---|---|
AIP | Â | Â | Â | 0.13 |
 Baseline | 0.49 ± 0.22 | 0.44 ± 0.19 | 0.36 | |
 Week 12 | 0.38 ± 0.28 | 0.41 ± 0.27 | 0.67 | |
 P | 0.007 | 0.33 |  | |
 Mean change | −0.11 ± 0.20 | −0.03 ± 0.16 | 0.10 | |
Castelli risk index I | Â | Â | Â | 0.46 |
 Baseline | 3.63 ± 0.9 | 3.41 ± 0.7 | 0.31 | |
 Week 12 | 3.38 ± 0.9 | 3.34 ± 0.7 | 0.88 | |
 P | 0.05 | 0.62 |  | |
 Mean change | −0.25 ± 0.6 | −0.07 ± 0.7 | 0.29 | |
Castelli risk index II | Â | Â | Â | 0.70 |
 Baseline | 2.11 ± 0.6 | 1.97 ± 0.5 | 0.55 | |
 Week 12 | 1.87 ± 0.6 | 1.83 ± 0.5 | 0.81 | |
 P | 0.01 | 0.15 |  | |
 Mean change | −0.24 ± 0.5 | −0.14 ± 0.5 | 0.47 | |
AC | Â | Â | Â | 0.40 |
 Baseline | 2.63 ± 0.9 | 2.41 ± 0.7 | 0.31 | |
 Week 12 | 2.38 ± 0.9 | 2.34 ± 0.7 | 0.88 | |
 P | 0.05 | 0.62 |  | |
 Mean change | −0.25 ± 0.6 | −0.07 ± 0.7 | 0.29 |